NCT00845988View on ClinicalTrials.gov

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Bipolar DisordersMetabolic Complication
Interventions
DRUG

aripiprazole

dosage form : po recommended dosage : more than 10mg/day duration : 28 weeks

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER